Out of 6,540 patients involved in a study, 7.1% of those with AD had mobility impairment compared to 3.9% of those without AD ...

The target action date for Rexulti in combination with sertraline to treat patients with post-traumatic stress disorder, ...

Health plans will need to navigate a difficult financial environment caused by increased healthcare costs and potential ...

Fianlimab plus Libtayo demonstrated persistent and significant clinical activity in patients with advanced melanoma.

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.

Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...